Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.
about
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.Detecting Tumor Metastases: The Road to Therapy Starts Here.Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.Markers of Prostate Cancer: The Role of Circulating Tumor Markers in the Management of Bone Metastases
P2860
Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Validation of a bone scan posi ...... ion-resistant prostate cancer.
@en
type
label
Validation of a bone scan posi ...... ion-resistant prostate cancer.
@en
prefLabel
Validation of a bone scan posi ...... ion-resistant prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Validation of a bone scan posi ...... tion-resistant prostate cancer
@en
P2093
Brian T Hanyok
Christopher J Kane
Christopher L Amling
Colette A Whitney
Floyd R Wilks
Jameson Y Kuang
Lauren E Howard
Martha K Terris
Matthew R Cooperberg
Stephen J Freedland
P2860
P304
P356
10.1111/BJU.13405
P577
2016-02-08T00:00:00Z